The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability

Konstas A. G., Labbe A., Katsanos A., Meier-Gibbons F., Irkec M., Boboridis K. G., ...Daha Fazla

EXPERT OPINION ON DRUG SAFETY, cilt.20, sa.4, ss.453-466, 2021 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 20 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1080/14740338.2021.1873947
  • Dergi Adı: EXPERT OPINION ON DRUG SAFETY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.453-466
  • Anahtar Kelimeler: BAK, benzalconium chloride, dry eye, glaucoma, intraocular pressure, IOP, ocular surface, ocular surface disease, OSD, preservative-free, OCULAR SURFACE DISEASE, BENZALKONIUM CHLORIDE, HYPERTENSION, COMBINATION, PREVALENCE, SYMPTOMS, ANALOGS, SIGNS, EYE
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction: Preservative-free (PF) medications represent a valuable treatment strategy in the lifelong management of glaucoma. By removing preservative toxicity, PF formulations provide tangible clinical benefits to glaucoma patients worldwide. They improve tolerability and adherence, leading to a positive impact in long-term intraocular pressure (IOP) control.